Minipress - Drug Details
📊 Estimates Minipress Dialyzability By Different_Modalities

Minipress

Complete Drug Information

Drug Name
Minipress
Trade Names
Minipress
Pregnancy Category
AU: B2
Bioavailability
~60%
Routes of Administration
Oral
Protein Binding
97%%
Elimination
2–3 hours
Formula
C19H21N5O4
Molar Mass
383.408
Onset of Action
30–90 minutes
Duration of Action
10–24 hours
Drug Class
α1 blocker
Volume of Distribution
C19H21N5O4

🤰 Pregnancy Category Information

Category: AU: B2

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.